|
May 2
|
Novo Nordisk shares jump as FDA accepts oral Wegovy application
|
|
May 2
|
US FDA accepts Novo Nordisk's application for oral Wegovy for weight loss
|
|
May 2
|
Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday
|
|
May 2
|
Eli Lilly’s Stock Selloff Is Overdone, Analysts Say. Here’s Why.
|
|
May 2
|
Eli Lilly stock sell-off was 'overreaction': Analysts
|
|
May 2
|
Is Most-Watched Stock Novo Nordisk A/S (NVO) Worth Betting on Now?
|
|
May 2
|
Update: Eli Lilly Brushes Off CVS Decision to Drop Zepbound Coverage
|
|
May 2
|
Stocks to watch next week: Berkshire Hathaway, Palantir, TSMC, Novo Nordisk and JD Wetherspoon
|
|
May 2
|
Is Novo Nordisk Stock a Buy?
|
|
May 2
|
Q1 2025 CVS Health Corp Earnings Call
|
|
May 1
|
CVS stock reacts to full-year guidance, Novo Nordisk GLP-1 deal
|
|
May 1
|
Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade'
|
|
May 1
|
3 things we've learned from healthcare earnings
|
|
May 1
|
Lilly’s Q1 2025 revenue jumps 45%, but CVS shift boosts Novo’s Wegovy
|
|
May 1
|
Eli Lilly slides, CVS earnings, Qualcomm's soft guidance
|
|
May 1
|
LLY's Q1 Earnings Miss, Mounjaro & Zepbound Drive Sales, Stock Down
|
|
May 1
|
CVS strikes a deal to offer Wegovy at a discount
|
|
May 1
|
Why Novo Nordisk Stock Popped Today
|
|
May 1
|
Eli Lilly's Q1 win outweighed by Novo's CVS deal
|
|
May 1
|
CVS Stock Surges On Huge Q1 Beat Amid GLP-1 Deal With Novo Nordisk
|